Evidence map›Paper›PMID 40404560›Full record

ArticleThe Journal of infectious diseases2025

Escherichia coli Type III Secretion System 2 Is Associated With Patient Mortality in Bloodstream Infections.

Joshua T Thaden, Phillip Cox, Paa Kwesi Ankrah, Sanjay Khandelwal, Jeffrey S Bourgeois, Orianna Poteete, Felicia Ruffin, Gowthami Arepally, Granger Sutton, Lauren Brinkac and 4 more

Abstract read
In one paragraph

Article in The Journal of infectious diseases, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Joshua T ThadenDivision of Infectious Diseases.ORCID 0000-0002-3250-0697
Phillip CoxDivision of Infectious Diseases.
Paa Kwesi AnkrahDivision of Infectious Diseases.
Sanjay KhandelwalDivision of Hematology.
Jeffrey S BourgeoisDepartment of Molecular Genetics and Microbiology, School of Medicine, Duke University, Durham, North Carolina.ORCID 0000-0001-9037-8418
Orianna PoteeteDivision of Infectious Diseases.
Felicia RuffinDivision of Infectious Diseases.ORCID 0000-0003-2176-6462
Gowthami ArepallyDivision of Hematology.ORCID 0000-0003-0496-5064
Granger SuttonJ. Craig Venter Institute, Rockville, Maryland.
Lauren BrinkacJ. Craig Venter Institute, Rockville, Maryland.
Thomas H ClarkeJ. Craig Venter Institute, Rockville, Maryland.
Dennis C KoDepartment of Molecular Genetics and Microbiology, School of Medicine, Duke University, Durham, North Carolina.ORCID 0000-0002-0113-5981
Derrick E FoutsJ. Craig Venter Institute, Rockville, Maryland.
Vance G FowlerDivision of Infectious Diseases.ORCID 0000-0002-8048-0897

Funding

The J. Craig Venter Institute Genome Center for Infectious DiseasesU19AI110819 · NIAID · J. CRAIG VENTER INSTITUTE, INC. · PI TAN, GENE · 2014 to 2018
$29.7M
Institutional Career Development CoreKL2TR002554 · NCATS · DUKE UNIVERSITY · PI SVETKEY, LAURA P · 2018 to 2022
$8.2M
HLA Fine Mapping to Elucidate S. aureus SusceptibilityR01AI165671 · NIAID · DUKE UNIVERSITY · PI FOWLER, VANCE G., SCOTT, WILLIAM K · 2021 to 2025
$3.8M
Characterization of a Novel E. coli Type III Secretion System Associated with Increased Patient MortalityK08AI171183 · NIAID · DUKE UNIVERSITY · PI Joshua T Thaden · 2022 to 2026
$895k
CDC Prevention Epicenter Program U54CK000603Duke University School of MedicineNCATS NIH HHS KL2 TR002554NCEZID CDC HHS U54 CK000603NIAID NIH HHS K08 AI171183NIAID NIH HHS R01 AI165671NIAID NIH HHS U19 AI110819NIH HHS K08 AI171183NIH HHS KL2 TR002554NIH HHS R01 AI165671NIH HHS U19 AI110819
6 · The paper itself

Abstract

backgroundEscherichia coli has an extensive accessory genome, though its role in affecting patient mortality is unknown.

methodsWe performed whole genome sequencing with E. coli bacteremia isolates. Pan-genome analysis was used to identify flexible genomic islands associated with in-hospital attributable mortality. Genomic islands of interest were investigated experimentally.

resultsWe included 193 E. coli genomes. Two genomic islands were co-present within 41 (21%) genomes and associated with increased attributable mortality in an adjusted analysis (Odds ratio 3.0; 95% confidence interval 1.1-7.9; p=0.03). The two genomic islands together contain genes homologous to a type III secretion system (T3SS): 1) E. coli type III secretion system 2 (ETT2), encoding genes homologous to a T3SS basal body and needle complex, and 2) an ETT2 accessory region (ETT2-AR) encoding genes homologous to a T3SS needle tip, translocases, and adhesin. ETT2/ETT2-AR increased resistance to complement-mediated growth restriction by inhibiting classical complement pathway activation and impacted E. coli-host cell interactions by increasing adhesion to and death of mammalian cells.

conclusionsGenomic islands ETT2 and ETT2-AR are homologous to a T3SS, co-localize within specific E. coli lineages, associate with increased mortality, and increase bacterial virulence through resistance to complement and enhanced host cell adhesion and death.

Indexed as

BacteremiaEscherichia coliEscherichia coli InfectionsEscherichia coli ProteinsType III Secretion SystemsFemaleGenome, BacterialGenomic IslandsHumansMaleWhole Genome SequencingEscherichia coli ProteinsType III Secretion Systemsbacteremiabloodstream infectionEscherichia coliETT2type III secretion system

Identifiers

PMID40404560
PMCPMC12614989

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.